Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer
Authors:
Open Access
- 25 October 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (2) , 2130-2140
Abstract
Detection of circulating tumor DNA in patients with advanced non-small cell lung cancerKeywords
This publication has 44 references indexed in Scilit:
- Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clampingJournal of Experimental & Clinical Cancer Research, 2013
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trialThe Lancet Oncology, 2012
- Integrative genomics viewerNature Biotechnology, 2011
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALKJournal of Clinical Oncology, 2009
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004